Who owns VYNE THERAPEUTICS INC?
- Ticker: VYNE
- CUSIP Number: 92941v308
Tip: Access positions for across all investors
Analyze quarterly positions in Vyne Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vyne Therapeutics stock
Who bought or sold VYNE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| ADAR1 Capital Management | 3.0M | $1.9M | 177% | Jun 2026 |
|
| Nantahala Capital Management | 2.0M | $1.3M | 0% | Jun 2026 |
|
| Lynx1 Capital Management | 1.6M | $1.1M | 0% | Jun 2026 |
|
| Shay Capital | 1.5M | $948k | -10% | Jun 2026 |
|
| T3 Companies | 945k | $615k | 0% | Jun 2026 |
|
| Braidwell | 916k | $596k | 0% | Jun 2026 |
|
| KVP Capital Advisors | 501k | $326k | 0% | Jun 2026 |
|
| Citadel Advisors | 469k | $305k | -9% | Jun 2026 |
|
| Two Sigma Investments | 439k | $286k | 3% | Jun 2026 |
|
| Acadian Asset Management | 382k | $248k | 0% | Jun 2026 |
|
| Ikarian Capital | 265k | $172k | 0% | Jun 2026 |
|
| Vanguard Capital Management | 265k | $172k | 0% | Jun 2026 |
|
| Geode Capital Management | 258k | $168k | -20% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 183k | $119k | 0% | Jun 2026 |
|
| Susquehanna International | 119k | $77k | 106% | Jun 2026 |
|
| Rangeley Capital | 113k | $74k | -4% | Jun 2026 |
|
| XTX Topco | 79k | $51k | -50% | Jun 2026 |
|
| GSA Capital Partners | 72k | $47k | 100% | Jun 2026 |
|
| Superstring Capital Management | 61k | $40k | 100% | Jun 2026 |
|
| UBS Group | 59k | $38k | -67% | Jun 2026 |
|
| BlackRock | 44k | $29k | 0% | Jun 2026 |
|
| Northern Trust | 44k | $28k | 89% | Jun 2026 |
|
| Jane Street | 41k | $27k | -57% | Jun 2026 |
|
| Two Sigma Securities | 41k | $27k | 100% | Jun 2026 |
|
| FNY Investment Advisers | 35k | $22k | 0% | Jun 2026 |
|
| Renaissance Technologies | 23k | $15k | 35% | Jun 2026 |
|
| Commonwealth Equity Services | 18k | $12k | 0% | Jun 2026 |
|
| State Street Corporation | 16k | $9.4k | 0% | Mar 2026 |
|
| Frigate Ventures | 15k | $9.4k | -99% | Jun 2026 |
|
| Tower Research Capital | 13k | $8.5k | 268% | Jun 2026 |
|
| Harvest Investment Services | 11k | $7.2k | 0% | Jun 2026 |
|
| Acorn Capital Advisors | 1.4k | $925.965000 | 0% | Jun 2026 |
|
| Mb, Levis & Associates | 1.0k | $676.962300 | 0% | Jun 2026 |
|
| Hurley Capital | 561.00 | $364.986600 | 0% | Jun 2026 |
|
| CWM | 500.00 | $299.000000 | 0% | Mar 2026 |
|
| Centerpoint Advisors | 350.00 | $0 | 0% | Jun 2026 |
|
| Barclays | 141.00 | $92.002500 | 100% | Jun 2026 |
|
| Wells Fargo & Company | 65.00 | $42.003000 | 0% | Jun 2026 |
|
| Morgan Stanley | 43.00 | $25.800000 | 0% | Mar 2026 |
|
| Truvestments Capital | 25.00 | $16.000000 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 15.00 | $0 | 0% | Jun 2026 |
|
| Newbridge Financial Services Group | 10.00 | $7.000000 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 8.00 | $5.000000 | 100% | Jun 2026 |
|
| Larson Financial Group | 2.00 | $1.000000 | 0% | Jun 2026 |
|
| Flagship Wealth Advisors | 1.00 | $1.000000 | 100% | Jun 2026 |
|
| Steward Partners Investment Advisory | 1.00 | $1.000000 | 100% | Jun 2026 |
|
Who sold out of Vyne Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boothbay Fund Management | Mar 2026 | 81k | $49k |
| Hrt Financial | Mar 2026 | 28k | $16k |
| Vanguard Global Advisers | Mar 2026 | 1.0k | $599.990400 |
| Northwestern Mutual Wealth Management Company | Mar 2026 | 800.00 | $478.000000 |